Just for a bit of a reality check on Swift: I requested and...

Just for a bit of a reality check on Swift:

I requested and witnessed SW1's shareholder register a few months ago and again recently. It indicated that only two out of the top 200 shareholders had been sellers of any note. So on that basis, any suggestion that the recent selling is coming from institutions/vendors/strategics is just plain wrong.

As other posters have noted, there is nothing mysterious or sinister in the company's operations or structure. Regarding the point raised earlier about shares issued to management, these relates to long term incentives based on shareholder-friendly three-year targets, and the $800k mgmt salary is two years' worth of compensation as noted in the accounts.

Based on today’s announcement, the Oneview deal appears to offer Swift a terrific springboard into a valuable existing network of hospital beds, with scope to grow this internationally along with ONE's own expansion plans.

Should be good buying here based on operational momentum and a compelling valuation.